WO2002046224A3 - Compositions et procedes relatifs a des genes et proteines specifiques des poumons - Google Patents

Compositions et procedes relatifs a des genes et proteines specifiques des poumons Download PDF

Info

Publication number
WO2002046224A3
WO2002046224A3 PCT/US2001/050687 US0150687W WO0246224A3 WO 2002046224 A3 WO2002046224 A3 WO 2002046224A3 US 0150687 W US0150687 W US 0150687W WO 0246224 A3 WO0246224 A3 WO 0246224A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
compositions
lung
antagonists
nucleic acids
Prior art date
Application number
PCT/US2001/050687
Other languages
English (en)
Other versions
WO2002046224A2 (fr
Inventor
Herve Recipon
Yongming Sun
Sei-Yu Chen
Chenghua Liu
Leah R Turner
Original Assignee
Diadexus Inc
Herve Recipon
Yongming Sun
Sei-Yu Chen
Chenghua Liu
Leah R Turner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc, Herve Recipon, Yongming Sun, Sei-Yu Chen, Chenghua Liu, Leah R Turner filed Critical Diadexus Inc
Priority to JP2002547960A priority Critical patent/JP2004520821A/ja
Priority to AU2002241730A priority patent/AU2002241730A1/en
Priority to EP01988422A priority patent/EP1355934A2/fr
Publication of WO2002046224A2 publication Critical patent/WO2002046224A2/fr
Publication of WO2002046224A3 publication Critical patent/WO2002046224A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention porte sur des acides nucléiques et des polypeptides récemment identifiés présents dans les cellules pulmonaires normales et néoplasiques y compris leurs fragments, variantes, et dérivés, ainsi que sur les anticorps de ces polypeptides et leurs agonistes et antagonistes. L'invention porte également sur des compositions comportant les susdits acides nucléiques et polypeptides et leurs anticorps, fragments, variantes, dérivés, agonistes et antagonistes, et sur l'utilisation de ces compositions à des fins d'identification, de diagnostic, de suivi, de stadification, et de traitement de cancers et d'états non cancéreux des poumons, ainsi que sur l'identification de tissus des poumons et le suivi et l'identification et/ou l'élaboration d'agonistes et d'antagonistes des susdits polypeptides. L'invention porte en outre sur une thérapie génique, et la production de tissus de poumon par génie génétique à des fins de traitement et de recherche.
PCT/US2001/050687 2000-10-26 2001-10-26 Compositions et procedes relatifs a des genes et proteines specifiques des poumons WO2002046224A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2002547960A JP2004520821A (ja) 2000-10-26 2001-10-26 肺特異的遺伝子およびタンパク質に関する組成物および方法
AU2002241730A AU2002241730A1 (en) 2000-10-26 2001-10-26 Compositions and methods relating to lung specific genes and proteins
EP01988422A EP1355934A2 (fr) 2000-10-26 2001-10-26 Compositions et procedes relatifs a des genes et proteines specifiques des poumons

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US24346100P 2000-10-26 2000-10-26
US60/243,461 2000-10-26
US25205500P 2000-11-20 2000-11-20
US60/252,055 2000-11-20
US25249600P 2000-11-22 2000-11-22
US60/252,496 2000-11-22

Publications (2)

Publication Number Publication Date
WO2002046224A2 WO2002046224A2 (fr) 2002-06-13
WO2002046224A3 true WO2002046224A3 (fr) 2003-08-21

Family

ID=27399666

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/050687 WO2002046224A2 (fr) 2000-10-26 2001-10-26 Compositions et procedes relatifs a des genes et proteines specifiques des poumons

Country Status (4)

Country Link
EP (1) EP1355934A2 (fr)
JP (1) JP2004520821A (fr)
AU (1) AU2002241730A1 (fr)
WO (1) WO2002046224A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012233044B2 (en) * 2002-11-22 2015-09-03 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and the use thereof
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
RU2678127C2 (ru) 2012-11-13 2019-01-23 Бионтех Аг Агенты для лечения экспрессирующих клаудин раковых заболеваний

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008206A1 (fr) * 1998-08-04 2000-02-17 Diadexus Llc Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
WO2001066751A2 (fr) * 2000-03-08 2001-09-13 Pharmacia & Upjohn Company Nouveaux recepteurs couples aux proteines g

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008206A1 (fr) * 1998-08-04 2000-02-17 Diadexus Llc Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
WO2001066751A2 (fr) * 2000-03-08 2001-09-13 Pharmacia & Upjohn Company Nouveaux recepteurs couples aux proteines g

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 10 April 1999 (1999-04-10), BATES, K.: "Human DNA sequence from clone RP1-231N13 on chromosome 6q22 contains GSSs", XP002231917, retrieved from EBI Database accession no. AL049613 *
DATABASE EMBL [online] 4 September 1998 (1998-09-04), ADAMS MD ET AL.: "CIT-HSP-2379F9.TR CIT-HSP Homo sapiens genomic clone 2379F9, genomic survey sequence", XP002231918, retrieved from EBI Database accession no. AQ111660 *
DATABASE GENBANK [online] 6 November 1998 (1998-11-06), GARDNER ET AL.: "Ser/Thr protein kinase (Plasmodium falciparum)", XP002231919, retrieved from NCBI Database accession no. AAC71910 (gi:3845228) *

Also Published As

Publication number Publication date
JP2004520821A (ja) 2004-07-15
AU2002241730A1 (en) 2002-06-18
WO2002046224A2 (fr) 2002-06-13
EP1355934A2 (fr) 2003-10-29

Similar Documents

Publication Publication Date Title
WO2002062945A3 (fr) Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
WO2002055735A3 (fr) Compositions et methodes en rapport avec des genes et des proteines specifiques de la prostate
WO2002040672A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux seins
WO2002064741A3 (fr) Compositions et methodes concernant des genes et des proteines specifiques du sein
WO2002040673A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux poumons
WO2002077232A3 (fr) Compositions et methodes relatives a des genes et a des proteines specifiques du sein
WO2004053075A3 (fr) Compositions, variants d'epissage et procedes relatifs a des genes et des proteines specifiques du sein
WO2002042463A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques a la prostate
WO2002064788A3 (fr) Compositions et procedes relatifs aux genes et aux proteines specifiques aux poumons
WO2003066877A3 (fr) Compositions et procedes se rapportant a des genes et proteines specifiques hepatiques
WO2002068645A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques pour le sein
WO2002039431A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques de la prostate
WO2002042776A3 (fr) Compositions contenant des genes et des proteines specifiques a la prostate, et methodes faisant appel a ces genes et proteines
WO2002046224A3 (fr) Compositions et procedes relatifs a des genes et proteines specifiques des poumons
WO2002088375A3 (fr) Compositions et procedes se rapportant aux genes et proteines specifiques au sein
WO2002066605A3 (fr) Compositions et procedes relatifs a des genes et a des proteines specifiques du sein
WO2004052290A3 (fr) Compositions, variants d'epissage et procedes concernant des genes et proteines specifiques du sein
WO2003020899A3 (fr) Compositions et methodes relatives a des genes et proteines specifiques des poumons
WO2002068633A3 (fr) Compositions et procedes concernant des genes et proteines specifiques aux poumons
WO2002048370A3 (fr) Compositions et methodes associees a des genes et a des proteines specifiques du colon
WO2003020953A3 (fr) Compositions et procedes concernant des genes et des proteines specifiques du colon
WO2002042329A3 (fr) Compositions et methodes se rapportant a des genes prostatiques specifiques et a des proteines
WO2002042499A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques a la prostate
WO2002077234A3 (fr) Compositions et methodes se rapportant aux genes et aux proteines specifiques du colon
WO2002042460A3 (fr) Compositions et procedes associes a des genes et a des proteines specifiques du colon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002547960

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001988422

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001988422

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001988422

Country of ref document: EP